Health Care & Life Sciences » Pharmaceuticals | Chunghwa Chemical Synthesis & Biotech Co. Ltd.

Chunghwa Chemical Synthesis & Biotech Co. Ltd. | Cash Flow

Fiscal year is January-December. All values TWD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
113,682.00
37,907.00
336,106.00
93,089.00
109,537.00
240,246
Depreciation, Depletion & Amortization
83,265.00
96,492.00
102,832.00
114,711.00
134,126.00
134,757
Other Funds
7,279.00
15,442.00
16,545.00
10,478.00
310.00
226,459
Funds from Operations
155,122.00
124,972.00
191,837.00
181,832.00
183,658.00
148,544
Changes in Working Capital
10,197.00
102,469.00
111,599.00
79,496.00
24,319.00
85,062
Net Operating Cash Flow
144,925.00
22,503.00
80,238.00
261,328.00
159,339.00
233,606
Capital Expenditures
110,044.00
146,589.00
129,278.00
114,856.00
808,918.00
Sale of Fixed Assets & Businesses
-
-
-
1,438.00
1,095.00
Purchase/Sale of Investments
9,838.00
15,000.00
16,298.00
-
21,684.00
Net Investing Cash Flow
119,900.00
160,700.00
533,674.00
131,486.00
786,139.00
Cash Dividends Paid - Total
116,340.00
77,560.00
38,780.00
116,340.00
38,780.00
Issuance/Reduction of Debt, Net
80,267.00
240,457.00
590,462.00
49,983.00
679,820.00
Net Financing Cash Flow
43,352.00
147,455.00
645,787.00
176,801.00
641,350.00
Net Change in Cash
17,710.00
9,971.00
31,190.00
47,186.00
12,915.00
Free Cash Flow
34,881.00
121,625.00
47,478.00
146,766.00
643,844.00
Net Assets from Acquisitions
-
-
-
17,208.00
-
Other Sources
-
889.00
679,250.00
-
-
Exchange Rate Effect
617.00
713.00
685.00
227.00
1,635.00
Other Uses
18.00
-
-
860.00
-

About Chunghwa Chemical Synthesis & Biotech Co.

View Profile
Address
No. 1 Dongxing Street
New Taipei TP 238 50
Taiwan
Employees -
Website http://www.ccsb.com.tw
Updated 07/08/2019
Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the manufacture of active pharmaceutical ingredient (API). Its products include pain management for skeletal muscle pain and migraine, immunosuppressant for reducing immune activity after organ transplant, antifungal such as fluconazole,caspofungin and micafungin, oncology that act against cancers, and other APIs for lowering cholesterol and anti diabetic drugs. The company was founded on May 19, 1964 and is headquartered in New Taipei, Taiwan.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.